ThermoGenesis Corp. (NASDAQ: KOOL) has their focus on the regenerative medicine market. This focus inspired the company to create a wholly-owned subsidiary named Vantus Inc. This subsidiary is a veterinary stem cell laboratory service that has collaborations with the UC Davis School of Veterinary Medicine’s Center for Equine Health and its Stem Cell Regenerative Medicine group to conduct research and development to enhance the collecting, processing, and storing of stem cells. For further information, visit the Company’s web site at www.thermogenesis.com.
- 17 years ago
QualityStocks
ThermoGenesis Corp. (NASDAQ: KOOL)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – VolitionRx (NYSE American: VNRX) Prepares Reimbursement Submission for Nu.Q Cancer Assays in France
VolitionRx Ltd. (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company, announced that it is preparing a reimbursement submission for its Nu.Q®…
-
QualityStocksNewsBreaks – Brand Engagement Network Inc. (NASDAQ: BNAI) Reports Warrant Exercises, Debt Conversion, and Public Warrants Update
Brand Engagement Network Inc. (NASDAQ: BNAI) announced on Wednesday that it generated approximately $1.46 million…
-
Soligenix (NASDAQ: SNGX) Positioning for Impact in Growing Rare-Disease Landscape
The World Health Organization’s recent recognition of rare diseases as a global health priority underscores…